Scrip is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Intrinsic raises $52mm via late-stage financing

Executive Summary

Spinal device maker Intrinsic Therapeutics Inc. raised $52mm in a late-stage series growth equity financing led by Questa Capital, which was joined by returning shareholders New Enterprise Associates, Greenspring Associates, Quadrille, and Delos Capital. The company will use the proceeds to prepare for the US commercialization of its Barricaid device, the first implant that can close the hole following lumbar discectomy surgery.
Deal Industry
  • Medical Devices
    • Implantable Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies